Umut Karabay

Umut Karabay

Auto-generated profile, based on publicly available information

Umut Karabay

Gülhane Eğitim Araştırma Hastanesi

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in European Journal of Breast Health
Verified
Journal Article
Open access
DADurmuş Ayan
Durmuş Ayan
Mehmet Ali GULMehmet Ali GUL
Mehmet Ali GUL
UKUmut Karabay
Umut Karabay
SBSeyyid Mehmet Bulut
Seyyid Mehmet Bulut
Bioinformatic Investigation of Genetic Changes in Paraoxonase Genes in Breast Cancer and Breast Cancer Subtypes - European Journal of Breast Health

1 November 2017 in Endocrinología, Diabetes y Nutrición
Verified
Journal Article
Closed access
SCSukru Cetin
Sukru Cetin
SYSuleyman Sezai Yildiz
Suleyman Sezai Yildiz
EMEmrah Erkan Mazı
Emrah Erkan Mazı
KKKudret Keskin
Kudret Keskin
GCGokhan Cetinkal
Gokhan Cetinkal
KKKadriye Orta Kilickesmez
Kadriye Orta Kilickesmez

22 January 2025 in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
Verified
Journal Article
Closed access
GKGULSAN KARABAY
GULSAN KARABAY
ZŞZeynep Şeyhanlı
Zeynep Şeyhanlı
SSSerap Topkara Sucu
Serap Topkara Sucu
BÇBetül Tokgöz Çakır
Betül Tokgöz Çakır
GAgizem aktemur
gizem aktemur
ŞÇŞevki Çelen
Şevki Çelen
Aim: Intrahepatic cholestasis of pregnancy (ICP) is a hepatic condition that occurs in 0.2-2% of pregnancies. It is characterized by intense itching and increased levels of bile acids in the bloodstream. Precise identification and anticipation of adverse neonatal outcomes are crucial. This study evaluates the diagnostic performance of liver-related scores—APRI (aspartate aminotransferase- platelet), ALBI (albumin-bilirubin), PALBI (platelet- albumin-bilirubin), and FAR (fibrinogen/albumin ratio) —in ICP patients and examines their relationship to pregnancy outcomes. Material and Method: This study was a retrospective analysis of 180 patients who were treated at Ankara Etlik City Hospital between January 2023 and January 2024. 90 ICP patients (Group 1) and 90 control patients (Group 2) were compared. The PALBI, ALBI, APRI scores, and FAR were calculated using third-trimester laboratory values. Neonatal outcomes, including birth weight, APGAR scores, NICU (neonatal intensive care unit) admission, sepsis, RDS (respiratory distress syndrome), and neonatal death were recorded. Statistical analyses included ROC (Receiver Operating Characteristics) curve analysis and Spearman correlation. Results: The PALBI, ALBI, APRI scores, and FAR were significantly higher in ICP patients (p-2.58 for PALBI (sensitivity 62%, specificity 81%), >-2.47 for ALBI (sensitivity 67%, specificity 81%), and >0.3 for APRI (sensitivity 78%, specificity 68%). Neonatal outcomes did not differ significantly between the groups. There was no correlation between fasting bile acid levels and liver damage markers with negative outcomes in newborns. Conclusion: In facilities where it is not possible to test fasting bile acid levels, PALBI, ALBI, APRI scores and FAR value offer an alternative approach to the evaluation of individuals with intrahepatic cholestasis of pregnancy (ICP). Future studies with larger patient groups are needed to increase the reliability of these parameters.

25 March 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
GKGULSAN KARABAY
GULSAN KARABAY
BBBurak Bayraktar
Burak Bayraktar
ZSZeynep Seyhanli
Zeynep Seyhanli
BÇBetül Tokgöz Çakır
Betül Tokgöz Çakır
GAgizem aktemur
gizem aktemur
AÇali turhan çağlar
ali turhan çağlar
To determine the role of sortilin in the pathogenesis of preeclampsia by examining serum sortilin levels in maternal blood. This prospective case-control study was conducted from May to November 2023 at the Perinatology Clinic of Ankara Etlik City Hospital. The study cohort was divided into two groups: Group 1 consisted of 44 pregnant women diagnosed with preeclampsia, and Group 2 served as the control group, comprising 44 healthy pregnant women. The groups were matched individually, with controls selected based on similar maternal age and gestational age at the time of sample collection. Maternal sortilin levels were significantly elevated in preeclampsia patients compared to controls. Using a cut-off value of > 3.57 ng/mL, sortilin levels could distinguish preeclampsia cases with a sensitivity of 90.9%, a specificity of 45.5%, and an area under the curve (AUC) of 0.679 (p = 0.002). At a cut-off of > 3.57 ng/mL, it was significantly associated with composite adverse neonatal outcomes, with a sensitivity of 89.6%, a specificity of 36.1%, and an AUC of 0.620 (p = 0.045). In addition, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and protein in 24-hour urine, which are important components in the diagnosis and severity of preeclampsia, were significantly correlated maternal blood sortilin levels. Our findings indicate that maternal sortilin levels are elevated in patients with preeclampsia compared to those in a healthy pregnant control group. Furthermore, maternal sortilin levels may predict adverse neonatal outcomes. In addition, sortilin levels are correlated key clinical markers of preeclampsia severity.

1 March 2024 in Journal of Surgery and Medicine
Verified
Journal Article
Open access
PDF file
EBErgul Bayram
Ergul Bayram
DADurmuş Ayan
Durmuş Ayan
TBTevfik Balcı
Tevfik Balcı
KAKader Zeybek Aydoğan
Kader Zeybek Aydoğan
DIDogan Bahadır Inan
Dogan Bahadır Inan
UKUmut Karabay
Umut Karabay
Background/Aim: Epidemiological investigations consistently indicate a widespread deficiency and insufficiency of vitamin D on a global scale. Vitamin D deficiency can lead to various acute and chronic diseases, including pre-eclampsia, autoimmune disorders, cardiovascular diseases, certain cancers, type 2 diabetes, and neurological disorders. However, the relationship between vitamin D status and its implications for global and public health has not been comprehensively explored. Notably, the differing clinical decision thresholds for diagnosing vitamin D deficiency and insufficiency established by various associations can create diagnostic confusion. Therefore, our study aimed to assess the distribution of vitamin D levels in Niğde province, considering variations by month, gender, and season, with respect to the clinical decision thresholds defined by different associations. Methods: The study sample comprised 57,731 cases (71% women and 19% men) admitted to our hospital between January 2021 and December 2022. We retrospectively evaluated 25-hydroxyvitamin D (25(OH)D) levels based on months, seasons, age, and gender. Additionally, we examined 25(OH)D levels separately using the clinical decision thresholds set by the Vitamin D Council, the Endocrine Society, and the Food and Nutrition Board. Patients with chronic renal insufficiency, hepatic insufficiency, and gastrointestinal malabsorption were excluded from the study, encompassing patients of all age groups. Furthermore, we categorized patients into different age decades and analyzed their vitamin D levels. We compared the same months in 2021 and 2022, monitoring changes in vitamin D levels throughout the year. Vitamin D levels were measured using the electrochemiluminescence assay (ECLIA) on a Roche Cobas E801 instrument. Results: When comparing the same months in 2021 and 2022, there was no statistically significant decrease or increase in 25(OH)D levels (The P-values for January and December were 0.066, 0.395, 0.907, 0.465, 0.705, 0.541, 0.625, 0.860, 0.695, 0.549, 0.892, and 0.838, respectively). Vitamin D insufficiency was observed in 70.3% of women and 29.7% of men. Participants under one year of age exhibited the highest mean 25(OH)D level (34.9 ng/mL), while participants between 20 and 29 years of age had the lowest mean 25(OH)D level (15.7 ng/mL). The lowest mean 25(OH)D level was recorded in April 2022 (15.6 ng/mL), whereas the highest mean 25(OH)D level was observed in July 2021 (22.7 ng/mL). There was a slight negative correlation between age and 25(OH)D levels (r=-0.038, P<0.001). The Vitamin D Council classification identified the highest number of patients with vitamin D deficiency (n=50,833; 88%). The Food and Nutrition Board included the lowest number of patients with vitamin D deficiency (n=15,049; 26.1%). Conclusion: Vitamin D deficiency is prevalent in Niğde province, particularly among women, and remains a significant public health concern. We advocate for the adoption of a unified clinical decision threshold and the expansion of the national vitamin D supplementation program to encompass adolescents and adults.

24 February 2025 in European Journal of Breast Health
Verified
Journal Article
Open access
DADurmuş Ayan
Durmuş Ayan
EBErgul Bayram
Ergul Bayram
HSHakan Sakallı
Hakan Sakallı
UKUmut Karabay
Umut Karabay
FYFatih Yay
Fatih Yay
Unveiling the Diagnostic Potential of Platelet-to-Lymphocyte Ratio and HALP Score in Newly Diagnosed Breast Cancer: A Step Toward Early Detection - European Journal of Breast Health